Susquehanna International Group, LLP Bio N Tech Se Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$80.36 - $102.87 $3.78 Million - $4.83 Million	-47,000 Reduced 17.07%	228,300 $18.3 Million
Q1 2024 May 07, 2024	SELL	$88.96 - $112.35 $6.52 Million - $8.24 Million	-73,300 Reduced 21.03%	275,300 $25.4 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $6.76 Million - $8.39 Million	-74,400 Reduced 17.59%	348,600 $36.8 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $20.5 Million - $26 Million	207,800 Added 96.56%	423,000 $46 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $533,416 - $674,232	5,200 Added 2.48%	215,200 $23.2 Million
Q1 2023 May 16, 2023	SELL	$122.57 - $153.67 $35.7 Million - $44.7 Million	-291,000 Reduced 58.08%	210,000 $26.2 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $2.55 Million - $4 Million	-21,500 Reduced 4.11%	501,000 $75.3 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $12.2 Million - $17.5 Million	-95,800 Reduced 15.49%	522,500 $70.5 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $10.5 Million - $15.8 Million	-85,100 Reduced 12.1%	618,300 $92.2 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $96.6 Million - $177 Million	-765,400 Reduced 52.11%	703,400 $120 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $43.3 Million - $72.5 Million	-199,900 Reduced 11.98%	1,468,800 $379 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $142 Million - $308 Million	688,300 Added 70.21%	1,668,700 $456 Million
Q2 2021 Aug 11, 2021	BUY	$113.32 - $241.49 $12.4 Million - $26.4 Million	109,400 Added 12.56%	980,400 $219 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $43.7 Million - $61 Million	510,200 Added 141.41%	871,000 $95.1 Million
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $1.3 Million - $2.32 Million	-17,900 Reduced 4.73%	360,800 $29.4 Million
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $17.2 Million - $30.9 Million	296,800 Added 362.39%	378,700 $26.2 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $3.16 Million - $5.47 Million	81,900 New	81,900 $5.47 Million

Others Institutions Holding BNTX

# of Institutions

328

Shares Held

40.6M

Call Options Held

845K

Put Options Held

1.23M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account